These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9272102)

  • 1. The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.
    Carroll PV; Littlewood R; Weissberger AJ; Bogalho P; McGauley G; Sönksen PH; Russell-Jones DL
    Eur J Endocrinol; 1997 Aug; 137(2):146-53. PubMed ID: 9272102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults.
    Gilchrist FJ; Murray RD; Shalet SM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):363-70. PubMed ID: 12201829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.
    McMillan CV; Bradley C; Gibney J; Healy ML; Russell-Jones DL; Sönksen PH
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):467-75. PubMed ID: 14510909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.
    Kehely A; Bates PC; Frewer P; Birkett M; Blum WF; Mamessier P; Ezzat S; Ho KK; Lombardi G; Luger A; Marek J; Russell-Jones D; Sönksen P; Attanasio AF
    J Clin Endocrinol Metab; 2002 May; 87(5):1974-9. PubMed ID: 11994327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
    Toogood AA; Shalet SM
    J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
    Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
    Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
    Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
    Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the desire for long-term growth hormone replacement in adults.
    Holmes SJ; Shalet SM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):151-7. PubMed ID: 7554309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.
    Mukherjee A; Tolhurst-Cleaver S; Ryder WD; Smethurst L; Shalet SM
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1542-9. PubMed ID: 15613427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
    Hayes FJ; Fiad TM; McKenna TJ
    Metabolism; 1999 Mar; 48(3):308-13. PubMed ID: 10094105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.
    Murray RD; Wieringa GE; Lissett CA; Darzy KH; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):525-32. PubMed ID: 11966746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.